You are invited to take part in a study called Women’s Chronic Pain and Prescribed Opioids. The study is being conducted by the Centre of Excellence for Women’s Health hosted by BC Women’s Hospital + Health Centre, Provincial Health Services Authority (PHSA). This research has received financial assistance from Health Canada's Substance Use Addition Program.
Lorraine Greaves, PhD
Senior Investigator, Centre of Excellence for Women's Health
Nancy Poole, PhD
Centre of Excellence for Women's Health
Lindsay Wolfson, MPH
Research Project Manager
Centre of Excellence for Women's Health
You are being invited to participate in this research study because you identify as a woman who has either have lived or living experiences of chronic pain and have been prescribed opioids for pain management.
PURPOSE OF THE STUDY
The goal of this project is to understand women’s perspectives, opinions, and experiences with chronic pain and prescribed opioids. The information collected will help to create health information for health care practitioners.
YOUR PARTICIPATION IS VOLUNTARY
Your participation in this project is entirely voluntary. It is up to you to decide whether or not to take part in this study. This consent form will tell you about the research project, why it is being completed, what will happen to you during the study, and the possible benefits, risks and discomforts associated with participation.
If you decide to take part in the study, you can withdraw at any time in the future without providing reasons for your decision. If you do not wish to participate, you do not have to provide any reasons for your decision.
Please take time to read the following information carefully. Feel free to contact the research team if you have any questions or concerns.
We have invited approximately 25 women who currently or have experienced chronic pain and have been prescribed opioids in a phone or Zoom interview about their perspectives, opinions, and experiences with chronic pain and prescribed opioids.
Before the interview, you will be sent a direct link to this consent form. If you choose to participate, you will be asked to take part in a semi-structured interview on Zoom, a secure virtual platform. At the beginning of the interview, Dr. Poole and Ms. Wolfson will review the consent form. By providing us your name and email address you agree to participate in this research.
These interviews will ask more detailed questions about prescription opioid use for pain management, your opinions and experiences about the prescribing process, and what information and materials women wish was available to healthcare providers. The interviews will last approximately 60 minutes, be audio-recorded and transcribed ad verbatim for analysis after video recording consent forms are obtained. All interviews will be conducted by October 15, 2022.
During this process, your identity will remain confidential, and at no time will your name or identity be disclosed or publicly stated by members of the research team.
Study participants may experience some discomfort talking about chronic pain and prescribed use if they have previously experienced stigma about their chronic illness or prescribed opioids from health care providers, family members or the public. Participants are encouraged to visit Wellness Together Canada, a virtual counselling service that can be used to connect with a counsellor 24/7 from anywhere in Canada if they experience discomfort.
Participants who complete the interview, will receive an $100 gift card to Well.ca for your time. Additionally, your responses may benefit women seeking pain management options in the future.
The information from this study will be used inform a) the creation of informational materials for health care providers around chronic pain and prescribed opioids, b) guidance for national professional organizations on how to update their curricula to reflect women’s experiences, and c) resource materials for interested healthcare practitioners, and health system planners.
A summary of the results and a link to the project page will be sent to you by March 31, 2024. The study findings may also be written up in journal articles or presentations. These materials will not include identifying information, such as your name.
Your identity will be kept confidential by the research team, and at no time will your any personal identification be publicly released by the research team. All interview data, including audio recordings, will be stored in a secure password protected platform (TitanFile) for a period of up to five years and then will be destroyed. Your name will not be in any publications or reports produced by the research team. The interview results will only be accessed by the research team.
Federal and provincial privacy laws give safeguards for privacy, security, and authorized access to information. We will not give information that identifies you to anyone without your permission, except as required by law.
Participants who choose to complete the semi-structured interview will receive an $100 gift card to Well.ca
CONTACT FOR INFORMATION ABOUT THE STUDY
If you have any questions or would like more information about this study, you may contact Project Manager, Lindsay Wolfson, at firstname.lastname@example.org.
CONTACT FOR CONCERNS ABOUT THE RIGHTS OF RESEARCH PARTICIPANTS
If you have any concerns or complaints about your rights as a research participant, your privacy, and/or your experiences while participating in this study, contact the Research Participant Complaint Line in the University of British Columbia Office of Research Ethics by e-mail at RSIL@ors.ubc.ca or by phone at 604-822-8598 (Toll Free: 1-877-822-8598). Please reference the study number H22-00942 when contacting the Complaint Line so the staff can better assist you.
There is 1 question in this survey.